首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 171 毫秒
1.
目的建立大鼠骨髓间充质干细胞的分离、培养方法,探讨电穿孔法介导外源基因转染骨髓间充质干细胞的可行性及转染效率.方法 Ficoll-PaqueTMPlus淋巴细胞分离液分离大鼠骨髓间充质干细胞(rMSCs)并进行原代培养和传代扩增,免疫组化的方法对其初步鉴定.用荧光显微镜、细胞计数法和流式细胞仪分析转染效率.结果电穿孔法可较高效转染rMSCs,转染率为(32.8%±3)%.该条件下电转染后的MSCs其生长曲线与转染前的细胞比较无明显变化.结论优化条件的电穿孔法具有较高的介导外源基因表达于rMSCs的效率,且对rMSCs的生物学行为没有明显影响.  相似文献   

2.
目的:分离、培养、纯化家猫的骨髓间充质干细胞,并对获得细胞的表面标志物进行鉴定,为进一步利用骨髓间充质干细胞的细胞移植实验奠定基础。方法:采用全骨髓贴壁法体外分离、培养、纯化家猫骨髓间充质干细胞,通过多次更换培养液获得较纯化的骨髓间充质干细胞,倒置相差显微镜下对细胞形态进行观察;根据第1、3、5、7、9代细胞的镜下增殖情况绘制出生长曲线;通过流式细胞仪检测细胞表面标志抗原CD34、CD44和CD90的表达率。结果:在倒置相差显微镜下观察,分离培养的骨髓间充质干细胞贴壁呈梭形或纺锤形;原代细胞生长丛集成片,5~7 d达到融合,进行传代;培养到第三代以后,细胞出现相对均匀的梭形扁平外观,迅速增殖的细胞呈涡流样排列;第3、5代骨髓间充质干细胞增殖能力强于第7、9代;采用流式细胞仪分析结果显示细胞的CD34、CD44和CD90阳性率分别为17.5%、97.9%和91%,这与骨髓间充质干细胞表面抗原的表达一致。结论:分离培养的细胞具有骨髓间充质干细胞特性,成分相对单一,第3、5代细胞纯度高,增殖能力强,适用于进一步的实验研究。  相似文献   

3.
目的:探讨人软骨细胞培养上清诱导冻存人骨髓充质干细胞向软骨细胞分化的可行性.方法:取进行全髋关节置换术老年患者的骨髓和软骨组织,利用密度梯度离心法、全骨髓培养法分别培养骨髓间充质干细胞,冻存备用.培养软骨细胞,观察细胞生长,收集软骨细胞培养上清.复苏冻存的人骨髓间充质干细胞,观察复苏后细胞生长状态.利用收集的软骨细胞培养上清对复苏间充质干细胞进行定向诱导,诱导培养2周,观察细胞外观表型变化,Ⅱ型胶原免疫组化检测诱导后人骨髓间充质干细胞Ⅱ型胶原的表达.结果:密度梯度离心法与全骨髓培养法均可分离获得人骨髓间充质干细胞,原代生长前者优于后者.复苏细胞仍进行可传代,与正常生长骨髓间充质细胞无明显差异,均可传至第8代.软骨细胞培养上清诱导2周后,细胞形状向圆形,多角形转变,冻存骨髓间充质干细胞Ⅱ型胶原免疫组化检测Ⅱ型胶原表达阳性.结论:老年人骨髓间充质干细胞仍具有向软骨细胞转化的能力,冻存不影响其转化能力.  相似文献   

4.
为培养及鉴定小鼠来源骨髓间充质干细胞,并测定细胞中Survivin的表达情况,采用全骨髓培养法获取骨髓间充质干细胞,绘制生长曲线,流式细胞仪检测细胞表面标志物,行成骨、成脂检测,RT-PCR测定Survivin表达情况.结果表明培养出的细胞呈长梭状成纤维细胞样,经流式细胞仪检测细胞表面高表达CD29、CD34、CD44、SCA-1,低表达CD117;细胞曲线显示传代细胞培养1~3d生长缓慢,第4d生长加快并于第7d达到高峰;成骨诱导20d经茜素红染色呈红色结节,成脂诱导14d油红O染色显示有大量脂质沉淀;RT-PCR结果显示Survivin mRNA阳性表达.经全骨髓培养法可以培养出大量骨髓间充质干细胞,同时Survivin在小鼠骨髓间充质干细胞中正常表达,提示可能参与骨髓间充质干细胞抗凋亡过程.  相似文献   

5.
目的通过分离扩增版纳微型猪骨髓间充质干细胞(BMSCs)观察传代对慢病毒转染的绿色荧光蛋白(GFP)表达的影响。方法采集4月龄版纳微型猪的骨髓,在DMEM/F12培养液中分离间充质干细胞(MSCs),并根据其形态学、抗原标志表达和分化潜能给予鉴定。MSCs与GFP慢病毒载体共培养,荧光显微镜观察GFP的表达,流式细胞仪检测传代后MSCs GFP表达率的变化。标记后传代至1、2、3、4代细胞间比较用非参数检验。结果采用直接培养骨髓,可以分离到高表达CD13、CD29、CD90、CD105的MSCs,并可诱导分化为脂肪、骨和软骨细胞。MSCs与携带GFP的慢病毒载体共培养3天即可观察到GFP的表达,最佳转染复数(MOI)值为50,最佳共培养时间为6 d。传代后MSCs GFP表达率呈下降趋势[1代转染率(42.3±2.25)%、2代转染率(41.6±2.65)%、3代转染率(41.4±3.75)%和4代转染率(38.2±4.75)%],但传至4代GFP表达率的变化差异无统计学意义(P0.05)。结论采用含有10%胎牛血清的DMEM/F12培养液可以从版纳微型猪骨髓中分离到MSCs,GFP慢病毒转染是标记MSCs的有效方法,连续传代4代不会显著影响GFP的表达。  相似文献   

6.
目的:探讨microRNA 499(miR-499)慢病毒转染对诱导大鼠骨髓来源间充质干细胞(BM-MSCs)向心肌样细胞分化的作用。方法:取第四代Wistar大鼠骨髓来源间充质干细胞进行流式细胞检测,鉴定干细胞表面特异标记物。使用符合干细胞鉴定标准的细胞批次用于后续实验。实验设置miR499慢病毒转染、慢病毒空白转染2个处理组,分别于处理后即日、1d,3d,5d,7d收集细胞进行下列实验:实时荧光定量PCR检测心肌重要转录因子GATA4、NKx2.5和MEF2C的mRNA表达,western-blot检测心肌特异蛋白I(cTnI)的表达。结果:培养第四代Wistar大鼠骨髓来源间充质干细胞表达干细胞表面特异标记物,可用于实验。大鼠骨髓来源间充质干细胞microRNA 499慢病毒载体转染后microRNA 499表达明显升高,且转染后1d,3d,5d,7d,GATA4、NKx2.5和MEF2C的mRNA表达逐渐增强。慢病毒空白转染组未见明显变化。western-blot检测自第3天开始可见cTnI阳性表达条带,慢病毒空白转染组未检测到明显阳性表达条带。结论:microRNA 499可诱导大鼠骨髓来源间充质干细胞向心肌样细胞分化。  相似文献   

7.
目的研究骨髓间充质干细胞分化为心肌细胞过程中Notch表达的研究。方法用密度梯度离心法分离培养犬骨髓间充质干细胞,按照酶法及差速贴壁法分离培养心肌细胞。观察干细胞增殖及传代情况。单独培养的干细胞为对照组,实验组将骨髓间充质干细胞与心肌细胞共培养,用RT-PCR、免疫细胞化学、MTT等方法检测干细胞分化为心肌细胞的情况,及干细胞在增殖与分化为心肌细胞过程中Notch信号系统的表达情况。结果骨髓间充质干细胞呈梭形、旋涡样生长,增殖及传代能力强,并可诱导分化为心肌样细胞,免疫荧光示心肌细胞标志物的表达。RT-PCR及免疫细胞化学显示实验组有Notch信号通路受体及配体的表达,而对照组表达微弱。结论骨髓间充质干细胞在增殖及分化过程中存在Notch信号通路,在干细胞分化为心肌细胞过程中Notch信号系统的表达上调。  相似文献   

8.
选用Wistar大鼠分离骨髓间充质干细胞作体外培养及鉴定其表达抗原CD44、CDw90;采用10μmol/L 5-氮胞苷诱导第1代的骨髓间充质干细胞,于诱导后2、4周进行免疫细胞化学反应检测α-横纹肌肌动蛋白、肌钙蛋白T。证实体外培养的第1代骨髓间充质干细胞经5-氮胞苷诱导可分化为心肌样细胞,为指导体外诱导的心肌细胞应用于。临床提供一定的理论依据和技术手段。  相似文献   

9.
目的:探讨蒙花苷(Linarin,LR)是否可以消除衰老骨髓间充质干细胞(BMSC)的衰老表型发挥抗衰老作用。方法:取4周龄80 g-100 g的雄性SD大鼠大腿骨髓腔内的骨髓间充质干细胞,用含10%胎牛血清的DMEM/F12培养基培养至三代,使用D-gal诱导骨髓间充质干细胞衰老,使用SA-β-gal染色、活性氧检测、蛋白免疫印迹验证骨髓间充质干细胞细胞衰老状态,通过蛋白免疫印迹检测衰老BMSC与正常BMSC中细胞保护性蛋白sirt1、sirt6及衰老相关蛋白p16、p21、p53的表达水平。之后,我们通过不同浓度LR处理衰老骨髓间充质干细胞。最后,通过蛋白印迹分析检测未处理组与LR处理组衰老相关蛋白表达情况。观察蒙花苷能否可以消除衰老的大鼠骨髓间充质干细胞衰老表型。结果:衰老的骨髓间充质干细胞细胞保护性蛋白sirt1、sirt6降低及衰老相关蛋白p16、p21、p53明显增高,衰老细胞中与DNA损伤相关的细胞核内蛋白γ-H2AX表达明显增加。而蒙花苷处理后,衰老细胞组衰老相关蛋白p16、p21、p53明显降低,γ-H2AX蛋白阳性细胞明显减少。结论:蒙花苷可以剂量依赖性的消除衰老的大鼠骨髓间充质干细胞的衰老表型发挥抗衰老作用。  相似文献   

10.
目的:诱导脐带华通胶间充质干细胞向Flk1阳性细胞分化。方法:胶原酶法分离培养脐带华通胶间充质干细胞,第3代细胞以含2-巯基乙醇的分化培养基培养,应用RT-PCR和流式细胞仪从mRNA和蛋白水平检测Flk1阳性细胞分化水平。结果:脐带华通胶间充质干细胞Flk1mRNA及蛋白表达极低,分化培养基培养后表达上调,48h达高峰(P〈0.05),之后表达降低。结论:2-巯基乙醇可诱导脐带华通胶间充质干细胞向Flk1阳性细胞分化,为从中分选Flk1阳性细胞进行进一步研究提供了依据  相似文献   

11.
12.
13.
Human bone marrow mesenchymal stem cells (hMSCs) are promising candidates for cell therapy and tissue engineering. The life span of hMSCs during in vitro culture is limited. Human telomerase catalytic subunit (hTERT) gene transduction can prolong the life span of hMSCs and maintain their potential of osteogenic differentiation. We established a line of hMSCs transduced with exogenous hTERT (hTERT-hMSCs) and investigated its sustaining cellular properties in a long-term culture. This line of hTERT-hMSCs was cultured for 290 population doublings (PDs) without loss of contact inhibition. Under adipogenic, chondrogenic and osteogenic induction, hTERT-hMSCs at PD 95 and PD 275 could differentiate respectively into adipocytes, chondrocytes, and osteocytes. hTERT-hMSCs at these PDs showed no transforming activity through both in vitro assay of cell growth in soft agar and in vivo assay of tumorigenicity in NOD-SCID mice. Karyotype analyses showed no significant chromosomal abnormalities in hTERT-hMSCs at these PDs. These results suggested that the hTERT-hMSCs at lower population doubling levels (PDLs) should be considered as a cell model for studies of cellular senescence, differentiation and in vitro tissue engineering experiment because of its prolonged life span and normal cellular properties.  相似文献   

14.
15.
16.
Genetically modified mesenchymal stem cells (MSCs) are potentially valuable tools for the novel treatment of human illnesses. Here, we investigated whether gene transfers by self-complementary adeno-associated viruses (scAAV) lead to promising genetic modification in human bone marrow and umbilical cord blood MSCs. Of the various scAAVs, scAAV2, and scAAV5 effectively and safely expressed transgenes in both hMSCs. Transduction efficiency with scAAV2 at 1000 multiplicity of infection was 66.3+/-9.4% and 67.6+/-6.7% in bone marrow and umbilical cord blood MSCs, respectively. A co-infection study showed that the distinct scAAV2 and scAAV5 can effectively express different transgenes in the same hMSC. hMSCs transduced by scAAVs showed long-term gene expression for three months in rat brains. Genetic modification by scAAVs did not affect osteogenic differentiation of hMSCs. Therefore, the present study strongly supports the promising potential of scAAVs as a technical platform for safe, long-term transgene expression in hMSCs.  相似文献   

17.
18.
19.
20.
Human mesenchymal stem cells (hMSC) are currently being introduced for cell therapy, yet, antibodies specific for native and differentiated MSCs are required for their identification prior to clinical use. Herein, high quality antibodies against MSC surface proteins were developed by immunizing mice with hMSC, and by using a panel of subsequent screening methods. Flow cytometry analysis revealed that 83.5, 1.1, and 8.5% of primary cultures of hMSC were double positive for STRO-1 and either of DJ 3, 9, and 18, respectively. However, none of the three DJ antibodies allowed enrichment of clonogenic hMSC from BMMNCs as single reagents. Using mass-spectrometric analysis, we identified the antigen recognised by DJ3 as CD44, whereas DJ9 and DJ18 recognized HLA-DRB1 and Collagen VI, respectively. The identified proteins were highly expressed throughout in vitro osteogenic- and adipogenic differentiation. Interestingly, undifferentiated cells revealed a sole cytoplasmic distribution pattern of Collagen VI, which however changed to an extracellular matrix appearance upon osteogenic- and adipogenic differentiation. In relation to this, we found that STRO-1+/−/Collagen VI sorted hMSC contained fewer differentiated alkaline phosphatase+ cells compared to STRO-1+/−/Collagen VI+ hMSC, suggesting that Collagen VI on the cell membrane exclusively defines differentiated MSCs. In conclusion, we have generated a panel of high quality antibodies to be used for characterization of MSCs, and in addition our results may suggest that the DJ18 generated antibody against Collagen VI can be used for negative selection of cultured undifferentiated MSCs.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号